The present invention relates to an ultrasonic aerosolization platform that has a single access port (10) provided with a trocar (11) inserted into the surgical cavity through a single incision and provided with at least one internal channel (101) in which is positioned an ultrasonic aerosolizer (20) provided with a head (21) that houses a power piezoelectric transducer (214) and a resonating rod (22) that extends orthogonally from the head (21), provided with an internal channel (221) in communication with the internal channel (212) of the head (21) and a free end (222) with an atomization nozzle (30) with orifices (31); a high-frequency ultrasound generator (40) that provides an electrical signal to the power piezoelectric transducer (214), which converts said electrical signal into mechanical oscillations transmitted to the resonating rod (22) in the form of mechanical standing waves; and a processing unit (50) provided with an interface (60) for adjusting the excitation frequency of the transducer (214), adjusting the flow of the therapeutic substance, and adjusting the operating and actuation time of the electrode (not shown) arranged in the resonating rod (22).

Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.

Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.

An example aerosol delivery device includes a mouthpiece having an airflow outlet, and an airflow passage extending between an airflow inlet and the airflow outlet. The example aerosol delivery device further includes a housing configured to receive a cartridge that includes an aerosolizable substance and a vapor element configured to heat the aerosolizable substance, and an internal power source configured to provide electrical power. The example aerosol delivery device further includes a controller coupled to the internal power source to receive a portion of the electrical power and configured to, when the cartridge is installed at the housing, cause the vapor element of the cartridge to heat the aerosolizable substance to release an aerosol into the airflow passage during an inhalation through the airflow outlet, and a connector configured to receive power from an external source to recharge the internal power source.

An inhaler and a method for adjusting the inhaler for inhaling a liquid pharmaceutical formulation and an inhaler with a nozzle for use with said method. The inhaler has a mouth piece portion with a lumen and a coupled body portion. The body portion has a body with a base facing the lumen. The body further includes a nozzle with an outlet for discharging said pharmaceutical formulation extending from the base into the lumen, a counter electrode at the base at a counter electrode distance from the nozzle outlet and a discharge electrode at a discharge electrode distance from the nozzle outlet. The inhaler further includes a power supply and an air inlet. The method includes a step of adjusting the electrode(s) relative to the nozzle outlet of the inhaler.

An inhaler and a method for adjusting the inhaler for inhaling a liquid pharmaceutical formulation and an inhaler with a nozzle for use with said method. The inhaler has a mouth piece portion with a lumen and a coupled body portion. The body portion has a body with a base facing the lumen. The body further includes a nozzle with an outlet for discharging said pharmaceutical formulation extending from the base into the lumen, a counter electrode at the base at a counter electrode distance from the nozzle outlet and a discharge electrode at a discharge electrode distance from the nozzle outlet. The inhaler further includes a power supply and an air inlet. The method includes a step of adjusting the electrode(s) relative to the nozzle outlet of the inhaler.

Illnesses result from individuals having insufficient cellular energy for normal functioning and to respond to various adverse events. In addition to receiving cellular energy from the metabolism of food, living creatures are dependent upon an environmental force termed KELEA, an abbreviation for Kinetic Energy Limiting Electrostatic Attraction. This energy drives what the Applicant refers to as the Alternative Cellular Energy (ACE) Pathway. It is expressed as an added dynamic or kinetic quality of the body's fluids. Water from various natural sources has varying levels of acquired KELEA. Various means are available to increase the level of KELEA in water. KELEA activated water has medicinal qualities in the prevention and cure of illnesses attributed to insufficient cellular energy. It is typically used in individual patients being either consumed as drinking water or used topically on the skin as a spray. The present invention describes the novel use of KELEA activated water in a humidifier to increase the overall environmental level of the KELEA activated water vapor in an enclosed environment. This approach is intended to enhance the ACE pathway of those present for; prolonged periods within such an environment. This can provide both incidental and directed benefits for large groups of individuals. This method is especially applicable when using KELEA activated water which is abundantly available from certain locations, including a location specified in this application.

Illnesses result from individuals having insufficient cellular energy for normal functioning and to respond to various adverse events. In addition to receiving cellular energy from the metabolism of food, living creatures are dependent upon an environmental force termed KELEA, an abbreviation for Kinetic Energy Limiting Electrostatic Attraction. This energy drives what the Applicant refers to as the Alternative Cellular Energy (ACE) Pathway. It is expressed as an added dynamic or kinetic quality of the body's fluids. Water from various natural sources has varying levels of acquired KELEA. Various means are available to increase the level of KELEA in water. KELEA activated water has medicinal qualities in the prevention and cure of illnesses attributed to insufficient cellular energy. It is typically used in individual patients being either consumed as drinking water or used topically on the skin as a spray. The present invention describes the novel use of KELEA activated water in a humidifier to increase the overall environmental level of the KELEA activated water vapor in an enclosed environment. This approach is intended to enhance the ACE pathway of those present for; prolonged periods within such an environment. This can provide both incidental and directed benefits for large groups of individuals. This method is especially applicable when using KELEA activated water which is abundantly available from certain locations, including a location specified in this application.

The invention relates to a nozzle for use in a device for administering a liquid medical formulation, to a method for producing the nozzle in the form of a microfluidic component and to a tool for producing microstructures of the microfluidic component. The nozzle is formed by a plastics plate with groove-like microstructures which are covered by a plastics cover on the longitudinal side in a fixed manner. The production method includes a moulding process in which a moulding tool is used, which moulding tool has complementary metal microstructures which have been produced from a semiconductor material in an electrodeposition process by means of a master component.

Systems and methods for nitric oxide (NO) generation systems are provided. In some embodiments, an NO generation system comprises at least one pair of electrodes configured to generate a product gas containing NO from a flow of a reactant gas. The electrodes have elongated surfaces such that a plasma produced is carried by the flow of the reactant gas and glides along the elongated surfaces from a first end towards a second end of the electrode pair. A controller is configured to regulate the amount of NO in the product gas by the at least one pair of electrodes using one or more parameters as an input to the controller. The one or more parameters include information from a plurality of sensors configured to collect information relating to at least one of the reactant gas, the product gas, and a medical gas into which the product gas flows.